Eris Lifesciences Limited (NSE:ERIS)

Eris Lifesciences Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct 17, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	217,441	192,990	114,719	77,801	93,615	82,147
Market Cap Growth	19.88%	68.23%	47.45%	-16.89%	13.96%	64.00%
Enterprise Value	244,339	221,970	121,268	80,085	92,600	80,183
Last Close Price	1596.40	1417.35	838.59	568.87	677.58	590.51
PE Ratio	56.30	54.85	29.26	20.36	23.05	23.13
Forward PE	36.60	38.80	25.79	17.15	21.23	21.38
PS Ratio	7.41	6.70	5.76	4.68	7.06	6.89
PB Ratio	6.65	5.90	3.56	3.50	4.91	5.21
P/TBV Ratio	-	-	-	-	8.10	10.28
P/FCF Ratio	-	21.21	32.15	-	36.39	23.50
P/OCF Ratio	-	18.12	23.60	26.67	24.75	21.89
PEG Ratio	1.05	1.29	1.61	1.91	1.46	1.14
EV/Sales Ratio	8.32	7.71	6.09	4.82	6.98	6.72
EV/EBITDA Ratio	22.59	22.09	18.30	15.23	19.18	18.82
EV/EBIT Ratio	33.22	31.59	24.53	18.99	21.81	20.69
EV/FCF Ratio	-	24.39	33.98	-	36.00	22.94
Debt / Equity Ratio	0.76	0.76	0.86	0.40	0.05	0.01
Debt / EBITDA Ratio	2.29	2.44	4.13	1.66	0.19	0.04
Debt / FCF Ratio	-	2.72	7.79	-	0.36	0.05
Asset Turnover	-	0.41	0.37	0.56	0.65	0.70
Inventory Turnover	-	2.80	2.47	2.90	2.49	2.95
Quick Ratio	-	0.56	0.75	1.22	1.99	1.78
Current Ratio	-	0.89	0.91	1.73	3.14	2.80
Return on Equity (ROE)	-	11.54%	14.59%	18.12%	23.29%	24.72%
Return on Assets (ROA)	-	6.24%	5.77%	8.87%	12.92%	14.31%
Return on Capital (ROIC)	7.81%	7.47%	6.78%	10.31%	14.76%	16.70%
Return on Capital Employed (ROCE)	-	12.40%	11.00%	13.10%	20.50%	23.20%
Earnings Yield	1.78%	1.82%	3.42%	4.91%	4.34%	4.32%
FCF Yield	-	4.71%	3.11%	-7.07%	2.75%	4.26%
Dividend Yield	0.46%	0.52%	-	1.29%	0.89%	0.93%
Payout Ratio	-	28.44%	-	26.14%	20.10%	21.03%
Buyback Yield / Dilution	-0.05%	-0.09%	-0.03%	-0.19%	-0.02%	1.03%
Total Shareholder Return	0.41%	0.43%	-0.03%	1.10%	0.86%	1.97%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.